Rabbit Polyclonal Antibody to Pembrolizumab
Pembrolizumab (Keytruda) is a humanized monoclonal antibody that is approved by the U.S. Food and Drug Administration for the treatment of patients with unresectable or metastatic melanoma. Pembrolizumab binds to the human cell surface receptor PD-1 (Programmed Cell Death Protein 1) and blocks its interaction with PD-L1, resulting in the activation of T-cell-mediated immune responses against tumor cells. Anti-Pembrolizumab Antibody, pAb, Rabbit is produced from sera of a rabbit immunized with Pembrolizumab.
Product Specifications
Host
Rabbit
Immunogen
Pembrolizumab
Clonality
Polyclonal
Applications
ELISA
Purification
Antigen affinity chromatography
Format
Purified
Components
0.5 mg/mL, lyophilized with PBS, pH 7.4, containing 0.02% sodium azide.
Storage Conditions
Applications Notes
ELISA detection: 0.01-0.1 ‚μg/mL
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items